HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Stock analysts at HC Wainwright issued their FY2027 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a research report issued to clients and investors on Monday, August 17th. HC Wainwright analyst M. Colonnese forecasts that the company will earn ($0.70) per share for the year.
Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, HIVE Blockchain Technologies currently has a consensus rating of “Buy”.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
